Watch for HSR clearance timeline and the launch of the rights offering (registration statement to be filed). The contaminant investigation at US Salt adds overhang; monitor FDA updates and any recall announcement. The 2027 FCF guidance range of $95-105M provides a benchmark for execution. If the deal closes successfully and US Salt issues are contained, LOGC could rerate significantly on a national exchange listing.
Price Chart
Executive Summary
ContextLogic (LOGC) announces the $850M cash acquisition of gChem, a vertically integrated specialty chemicals company and the sole Western Hemisphere producer of DMSO, as its second operating business following US Salt. The transaction is financed via a fully backstopped $650M rights offering at $9/unit and $250M in debt. Separately, LOGC reports preliminary Q2 2026 results showing flat revenue of $33.6M and gross margin contraction to 37%, and discloses a contaminant investigation at US Salt that could lead to a product recall. The acquisition is expected to close in Q4 2026 and is projected to generate $95-105M in combined free cash flow for FY 2027.
Key Financial Metrics
Key Facts
- All-cash purchase of gChem for $850M, subject to customary adjustments; financed via $650M rights offering (fully backstopped at $9/unit) and $250M debt from Blackstone Credit & Insurance.
- gChem is the only Western Hemisphere producer of DMSO at scale, serves pharma, semiconductor, agri, and aerospace end markets, with 19.2% reported operating income CAGR (2019–LTM Mar 2026).
- CEO Frank Roederer enters a 5-year employment agreement and rolls $2M of equity into ContextLogic via a management rollover.
- Preliminary Q2 2026 revenue $33.6M (flat vs $33.8M YoY), gross profit $12.5M (-8.8% YoY), gross margin 37% vs 41%.
- US Salt self-reported a contaminant in a Feb 2026 production lot to the FDA; possible recall could materially affect US Salt's business and financial performance.
- Pro forma FY 2027 free cash flow expected $95–105M on ~174M units outstanding of ContextLogic Holdings, LLC.
- Transaction expected to close by end of 2026, subject to HSR clearance and other customary conditions.
Financial Impact
The $850M acquisition transforms LOGC's scale; pro forma 2027 FCF of $95–105M implies significant accretion if realized. The rights offering at $9/unit is dilutive to existing holders but backstopped. US Salt contaminant risk could impose recall costs and revenue loss.
Risk Factors
- Regulatory delay or failure to obtain HSR clearance by May 2027 outside date (extendable to June 2027).
- US Salt contaminant recall escalates, causing material financial and reputational damage.
- Rights offering backstop at $9/unit signals potential downside risk to current stock price; dilution may weigh on near-term valuation.
- Integration of gChem and realization of expected free cash flow may fall short of guidance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-333861 |
| Document: logc-20260804.htm | 0001193125-26-333861 |
| Document: logc-ex99_2.htm | 0001193125-26-333861 |
| Document: logc-ex99_1.htm | 0001193125-26-333861 |
| Document: 0001193125-26-333861-index-headers.html | 0001193125-26-333861 |
| Document: 0001193125-26-333861-index.html | 0001193125-26-333861 |
| Document: 0001193125-26-333861.txt | 0001193125-26-333861 |
| 8-K Data (Synthetic) | 0001193125-26-333861 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $15.25 | awaiting T+60 | — | $15.29 (+0.26%) |
Aug 5, 2026 11w ago | 8-K | $9.92 | awaiting T+60 | — | $15.29 (+54.13%) |
Jun 15, 2026 19w ago | Insider Cluster | $9.63 $14.01 | ▲ +45.48% | ▲ +44.22% | $15.29 (+58.77%) |
Jun 3, 2026 20w ago | 3 | $9.00 $12.62 | ▲ +40.22% | ▲ +37.72% | $15.29 (+69.89%) |
May 15, 2026 23w ago | 8-K | $8.63 $10.34 | ▲ +19.81% | ▲ +15.30% | $15.29 (+77.17%) |
Apr 3, 2026 29w ago | 3 | $8.13 $8.90 | ▲ +9.47% | ▼ −4.00% | $15.29 (+88.07%) |
Mar 5, 2026 33w ago | 8-K/A | $7.90 $9.05 | ▲ +14.56% | ▲ +1.78% | $15.29 (+93.54%) |
Mar 5, 2026 33w ago | 8-K | $7.90 $9.05 | ▲ +14.56% | ▲ +1.78% | $15.29 (+93.54%) |
Feb 26, 2026 34w ago | Insider Cluster | $8.09 $8.70 | ▲ +7.54% | ▼ −1.85% | $15.29 (+89.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers